nodes	percent_of_prediction	percent_of_DWPC	metapath
Enoxacin—CYP1A2—Carmustine—melanoma	0.377	0.417	CbGbCtD
Enoxacin—CYP1A2—Vemurafenib—melanoma	0.298	0.33	CbGbCtD
Enoxacin—CYP1A2—Dacarbazine—melanoma	0.229	0.253	CbGbCtD
Enoxacin—TOP2A—Paclitaxel—Docetaxel—melanoma	0.00919	1	CbGdCrCtD
Enoxacin—TOP2A—Validated transcriptional targets of deltaNp63 isoforms—FASN—melanoma	0.00151	0.0176	CbGpPWpGaD
Enoxacin—CYP1A2—Synthesis of epoxy (EET) and dihydroxyeicosatrienoic acids (DHET)—CYP1B1—melanoma	0.00149	0.0173	CbGpPWpGaD
Enoxacin—TOP2A—Mitotic G1-G1/S phases—PKMYT1—melanoma	0.00143	0.0167	CbGpPWpGaD
Enoxacin—CYP1A2—Synthesis of (16-20)-hydroxyeicosatetraenoic acids (HETE)—CYP1B1—melanoma	0.00135	0.0158	CbGpPWpGaD
Enoxacin—TOP2A—Gastric Cancer Network 1—NOTCH1—melanoma	0.00123	0.0143	CbGpPWpGaD
Enoxacin—TOP2A—Gastric Cancer Network 1—APC—melanoma	0.0012	0.014	CbGpPWpGaD
Enoxacin—CYP1A2—Melatonin metabolism and effects—MAP2—melanoma	0.00119	0.0138	CbGpPWpGaD
Enoxacin—TOP2A—Validated transcriptional targets of deltaNp63 isoforms—VDR—melanoma	0.00113	0.0131	CbGpPWpGaD
Enoxacin—TOP2A—Circadian rythm related genes—ARNT—melanoma	0.00112	0.013	CbGpPWpGaD
Enoxacin—TOP2A—Circadian rythm related genes—PAX4—melanoma	0.00108	0.0126	CbGpPWpGaD
Enoxacin—TOP2A—Integrated Pancreatic Cancer Pathway—CAPN1—melanoma	0.00106	0.0123	CbGpPWpGaD
Enoxacin—TOP2A—Retinoblastoma (RB) in Cancer—SKP2—melanoma	0.00103	0.012	CbGpPWpGaD
Enoxacin—CYP1A2—Estrogen Receptor Pathway—CYP1B1—melanoma	0.00101	0.0117	CbGpPWpGaD
Enoxacin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—ARNT—melanoma	0.000954	0.0111	CbGpPWpGaD
Enoxacin—CYP1A2—Aryl Hydrocarbon Receptor—ARNT—melanoma	0.000954	0.0111	CbGpPWpGaD
Enoxacin—TOP2A—Validated transcriptional targets of deltaNp63 isoforms—ATM—melanoma	0.000869	0.0101	CbGpPWpGaD
Enoxacin—TOP2A—Integrated Pancreatic Cancer Pathway—NODAL—melanoma	0.00085	0.00991	CbGpPWpGaD
Enoxacin—TOP2A—Validated transcriptional targets of deltaNp63 isoforms—NOTCH1—melanoma	0.000833	0.0097	CbGpPWpGaD
Enoxacin—CYP1A2—Phase II conjugation—UGT2B10—melanoma	0.000778	0.00907	CbGpPWpGaD
Enoxacin—CYP1A2—Estrogen metabolism—CYP1B1—melanoma	0.000777	0.00906	CbGpPWpGaD
Enoxacin—TOP2A—Gastric Cancer Network 2—CTNNB1—melanoma	0.000772	0.00899	CbGpPWpGaD
Enoxacin—TOP2A—Integrated Pancreatic Cancer Pathway—MAP3K5—melanoma	0.000758	0.00883	CbGpPWpGaD
Enoxacin—TOP2A—Integrated Pancreatic Cancer Pathway—CASP10—melanoma	0.000758	0.00883	CbGpPWpGaD
Enoxacin—TOP2A—Mitotic G1-G1/S phases—SKP2—melanoma	0.000723	0.00843	CbGpPWpGaD
Enoxacin—TOP2A—Integrated Pancreatic Cancer Pathway—DCC—melanoma	0.0007	0.00816	CbGpPWpGaD
Enoxacin—CYP1A2—Tamoxifen metabolism—CYP1B1—melanoma	0.000687	0.008	CbGpPWpGaD
Enoxacin—TOP2A—Integrated Pancreatic Cancer Pathway—APAF1—melanoma	0.00068	0.00792	CbGpPWpGaD
Enoxacin—TOP2A—Validated transcriptional targets of deltaNp63 isoforms—CDKN2A—melanoma	0.000661	0.0077	CbGpPWpGaD
Enoxacin—TOP2A—Retinoblastoma (RB) in Cancer—E2F1—melanoma	0.000648	0.00756	CbGpPWpGaD
Enoxacin—TOP2A—Integrated Pancreatic Cancer Pathway—WT1—melanoma	0.000645	0.00751	CbGpPWpGaD
Enoxacin—TOP2A—Validated transcriptional targets of deltaNp63 isoforms—MDM2—melanoma	0.000641	0.00747	CbGpPWpGaD
Enoxacin—TOP2A—Cell Cycle—REC8—melanoma	0.000641	0.00747	CbGpPWpGaD
Enoxacin—TOP2A—Gastric Cancer Network 2—MYC—melanoma	0.000625	0.00728	CbGpPWpGaD
Enoxacin—TOP2A—Retinoblastoma (RB) in Cancer—PCNA—melanoma	0.000611	0.00713	CbGpPWpGaD
Enoxacin—TOP2A—Gastric Cancer Network 2—EGFR—melanoma	0.000611	0.00712	CbGpPWpGaD
Enoxacin—TOP2A—Retinoblastoma (RB) in Cancer—CDK2—melanoma	0.000559	0.00652	CbGpPWpGaD
Enoxacin—CYP1A2—Melatonin metabolism and effects—CYP1B1—melanoma	0.000531	0.00618	CbGpPWpGaD
Enoxacin—TOP2A—Retinoblastoma (RB) in Cancer—CDK4—melanoma	0.000528	0.00616	CbGpPWpGaD
Enoxacin—TOP2A—Cell Cycle, Mitotic—INCENP—melanoma	0.000526	0.00613	CbGpPWpGaD
Enoxacin—TOP2A—Cell Cycle, Mitotic—PKMYT1—melanoma	0.000526	0.00613	CbGpPWpGaD
Enoxacin—TOP2A—Gastric Cancer Network 2—TP53—melanoma	0.000513	0.00598	CbGpPWpGaD
Enoxacin—TOP2A—Mitotic G1-G1/S phases—CDKN2B—melanoma	0.000497	0.00579	CbGpPWpGaD
Enoxacin—TOP2A—Circadian rythm related genes—GNA11—melanoma	0.000481	0.00561	CbGpPWpGaD
Enoxacin—TOP2A—Cell Cycle—INCENP—melanoma	0.00047	0.00548	CbGpPWpGaD
Enoxacin—TOP2A—Cell Cycle—PKMYT1—melanoma	0.00047	0.00548	CbGpPWpGaD
Enoxacin—TOP2A—Retinoblastoma (RB) in Cancer—RB1—melanoma	0.00046	0.00536	CbGpPWpGaD
Enoxacin—TOP2A—Mitotic G1-G1/S phases—E2F1—melanoma	0.000456	0.00532	CbGpPWpGaD
Enoxacin—CYP1A2—Biological oxidations—UGT2B10—melanoma	0.000455	0.00531	CbGpPWpGaD
Enoxacin—TOP2A—Circadian rythm related genes—HDAC2—melanoma	0.000452	0.00527	CbGpPWpGaD
Enoxacin—TOP2A—Circadian rythm related genes—GNAQ—melanoma	0.000447	0.00521	CbGpPWpGaD
Enoxacin—TOP2A—Mitotic G1-G1/S phases—PCNA—melanoma	0.00043	0.00501	CbGpPWpGaD
Enoxacin—CYP1A2—Melatonin metabolism and effects—EDN1—melanoma	0.000429	0.005	CbGpPWpGaD
Enoxacin—TOP2A—Circadian rythm related genes—NGFR—melanoma	0.000413	0.00481	CbGpPWpGaD
Enoxacin—CYP1A2—Melatonin metabolism and effects—PRKCA—melanoma	0.000402	0.00469	CbGpPWpGaD
Enoxacin—Gatifloxacin—ALB—melanoma	0.0004	0.537	CrCbGaD
Enoxacin—TOP2A—Cell Cycle—POT1—melanoma	0.000396	0.00462	CbGpPWpGaD
Enoxacin—TOP2A—Mitotic G1-G1/S phases—CDK2—melanoma	0.000393	0.00459	CbGpPWpGaD
Enoxacin—TOP2A—Retinoblastoma (RB) in Cancer—MDM2—melanoma	0.000392	0.00457	CbGpPWpGaD
Enoxacin—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—melanoma	0.000385	0.00448	CbGpPWpGaD
Enoxacin—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—melanoma	0.000384	0.00447	CbGpPWpGaD
Enoxacin—TOP2A—Integrated Pancreatic Cancer Pathway—CDKN2B—melanoma	0.000377	0.00439	CbGpPWpGaD
Enoxacin—TOP2A—Mitotic G1-G1/S phases—CDK4—melanoma	0.000372	0.00433	CbGpPWpGaD
Enoxacin—TOP2A—Integrated Pancreatic Cancer Pathway—ABCB1—melanoma	0.000368	0.00429	CbGpPWpGaD
Enoxacin—CYP1A2—Aryl Hydrocarbon Receptor—CYP1B1—melanoma	0.000367	0.00427	CbGpPWpGaD
Enoxacin—CYP1A2—Tryptophan metabolism—CYP1B1—melanoma	0.000367	0.00427	CbGpPWpGaD
Enoxacin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—CYP1B1—melanoma	0.000367	0.00427	CbGpPWpGaD
Enoxacin—TOP2A—Retinoblastoma (RB) in Cancer—CDKN1B—melanoma	0.000358	0.00417	CbGpPWpGaD
Enoxacin—CYP1A2—Estrogen Receptor Pathway—STAT3—melanoma	0.000354	0.00413	CbGpPWpGaD
Enoxacin—TOP2A—Integrated Pancreatic Cancer Pathway—FGF1—melanoma	0.000353	0.00412	CbGpPWpGaD
Enoxacin—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP17A1—melanoma	0.000352	0.00411	CbGpPWpGaD
Enoxacin—CYP1A2—Oxidation by Cytochrome P450—CYP17A1—melanoma	0.000348	0.00405	CbGpPWpGaD
Enoxacin—TOP2A—Integrated Pancreatic Cancer Pathway—E2F1—melanoma	0.000346	0.00403	CbGpPWpGaD
Enoxacin—CYP1A2—Arachidonic acid metabolism—CYP1B1—melanoma	0.000343	0.004	CbGpPWpGaD
Enoxacin—TOP2A—Integrated Pancreatic Cancer Pathway—PDGFRA—melanoma	0.000342	0.00399	CbGpPWpGaD
Enoxacin—TOP2A—Retinoblastoma (RB) in Cancer—CCND1—melanoma	0.000341	0.00398	CbGpPWpGaD
Enoxacin—TOP2A—Integrated Pancreatic Cancer Pathway—PRKCA—melanoma	0.000339	0.00395	CbGpPWpGaD
Enoxacin—TOP2A—Integrated Pancreatic Cancer Pathway—FASLG—melanoma	0.000332	0.00387	CbGpPWpGaD
Enoxacin—TOP2A—Retinoblastoma (RB) in Cancer—CDKN1A—melanoma	0.00033	0.00385	CbGpPWpGaD
Enoxacin—TOP2A—Integrated Pancreatic Cancer Pathway—PCNA—melanoma	0.000326	0.0038	CbGpPWpGaD
Enoxacin—TOP2A—Mitotic G1-G1/S phases—RB1—melanoma	0.000323	0.00377	CbGpPWpGaD
Enoxacin—TOP2A—Integrated Pancreatic Cancer Pathway—FAS—melanoma	0.00032	0.00373	CbGpPWpGaD
Enoxacin—TOP2A—Integrated Pancreatic Cancer Pathway—RAC1—melanoma	0.000314	0.00366	CbGpPWpGaD
Enoxacin—TOP2A—Circadian rythm related genes—FAS—melanoma	0.000307	0.00358	CbGpPWpGaD
Enoxacin—TOP2A—Integrated Pancreatic Cancer Pathway—CDK2—melanoma	0.000298	0.00347	CbGpPWpGaD
Enoxacin—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP1B1—melanoma	0.000297	0.00346	CbGpPWpGaD
Enoxacin—CYP1A2—Oxidation by Cytochrome P450—CYP1B1—melanoma	0.000293	0.00341	CbGpPWpGaD
Enoxacin—CYP1A2—Metapathway biotransformation—AKR1B10—melanoma	0.000289	0.00337	CbGpPWpGaD
Enoxacin—CYP1A2—Phase 1 - Functionalization of compounds—CYP17A1—melanoma	0.000286	0.00333	CbGpPWpGaD
Enoxacin—TOP2A—Mitotic G1-G1/S phases—CDKN2A—melanoma	0.000284	0.00331	CbGpPWpGaD
Enoxacin—CYP1A2—Aryl Hydrocarbon Receptor—E2F1—melanoma	0.000284	0.00331	CbGpPWpGaD
Enoxacin—TOP2A—Integrated Pancreatic Cancer Pathway—ATM—melanoma	0.000283	0.0033	CbGpPWpGaD
Enoxacin—TOP2A—Integrated Pancreatic Cancer Pathway—CDK4—melanoma	0.000282	0.00328	CbGpPWpGaD
Enoxacin—TOP2A—Retinoblastoma (RB) in Cancer—MYC—melanoma	0.000274	0.00319	CbGpPWpGaD
Enoxacin—TOP2A—Circadian rythm related genes—CDK4—melanoma	0.00027	0.00315	CbGpPWpGaD
Enoxacin—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—melanoma	0.000268	0.00312	CbGpPWpGaD
Enoxacin—TOP2A—Cell Cycle, Mitotic—SKP2—melanoma	0.000265	0.00309	CbGpPWpGaD
Enoxacin—TOP2A—Integrated Pancreatic Cancer Pathway—APC—melanoma	0.000265	0.00309	CbGpPWpGaD
Enoxacin—TOP2A—Circadian rythm related genes—NOS2—melanoma	0.000263	0.00306	CbGpPWpGaD
Enoxacin—TOP2A—Integrated Pancreatic Cancer Pathway—EGF—melanoma	0.000262	0.00306	CbGpPWpGaD
Enoxacin—TOP2A—Mitotic G1-G1/S phases—CDKN1B—melanoma	0.000252	0.00293	CbGpPWpGaD
Enoxacin—TOP2A—Integrated Pancreatic Cancer Pathway—CASP8—melanoma	0.000247	0.00288	CbGpPWpGaD
Enoxacin—TOP2A—Circadian rythm related genes—PPARG—melanoma	0.000246	0.00286	CbGpPWpGaD
Enoxacin—CYP1A2—Aryl Hydrocarbon Receptor—CDK2—melanoma	0.000245	0.00285	CbGpPWpGaD
Enoxacin—TOP2A—Integrated Pancreatic Cancer Pathway—IGF1—melanoma	0.000243	0.00283	CbGpPWpGaD
Enoxacin—TOP2A—Cell Cycle, Mitotic—AURKA—melanoma	0.000243	0.00283	CbGpPWpGaD
Enoxacin—CYP1A2—Phase 1 - Functionalization of compounds—CYP1B1—melanoma	0.00024	0.0028	CbGpPWpGaD
Enoxacin—TOP2A—Mitotic G1-G1/S phases—CCND1—melanoma	0.00024	0.0028	CbGpPWpGaD
Enoxacin—TOP2A—Cell Cycle—MLH1—melanoma	0.00024	0.0028	CbGpPWpGaD
Enoxacin—TOP2A—Cell Cycle—SKP2—melanoma	0.000237	0.00276	CbGpPWpGaD
Enoxacin—TOP2A—Integrated Pancreatic Cancer Pathway—MAP2K1—melanoma	0.000235	0.00274	CbGpPWpGaD
Enoxacin—TOP2A—Mitotic G1-G1/S phases—CDKN1A—melanoma	0.000232	0.00271	CbGpPWpGaD
Enoxacin—TOP2A—Retinoblastoma (RB) in Cancer—TP53—melanoma	0.000225	0.00262	CbGpPWpGaD
Enoxacin—TOP2A—Integrated Pancreatic Cancer Pathway—FGF2—melanoma	0.000223	0.0026	CbGpPWpGaD
Enoxacin—TOP2A—Cell Cycle—AURKA—melanoma	0.000217	0.00253	CbGpPWpGaD
Enoxacin—TOP2A—Integrated Pancreatic Cancer Pathway—BCL2—melanoma	0.000212	0.00247	CbGpPWpGaD
Enoxacin—TOP2A—Cell Cycle, Mitotic—APEX1—melanoma	0.000211	0.00246	CbGpPWpGaD
Enoxacin—TOP2A—Integrated Pancreatic Cancer Pathway—MDM2—melanoma	0.000209	0.00243	CbGpPWpGaD
Enoxacin—CYP1A2—Melatonin metabolism and effects—NFKB1—melanoma	0.000208	0.00242	CbGpPWpGaD
Enoxacin—TOP2A—Integrated Pancreatic Cancer Pathway—ERBB2—melanoma	0.000206	0.0024	CbGpPWpGaD
Enoxacin—TOP2A—Integrated Pancreatic Cancer Pathway—PTGS2—melanoma	0.000201	0.00235	CbGpPWpGaD
Enoxacin—CYP1A2—Aryl Hydrocarbon Receptor—RB1—melanoma	0.000201	0.00234	CbGpPWpGaD
Enoxacin—CYP1A2—Aryl Hydrocarbon Receptor—MAP2K1—melanoma	0.000193	0.00225	CbGpPWpGaD
Enoxacin—TOP2A—Mitotic G1-G1/S phases—MYC—melanoma	0.000193	0.00224	CbGpPWpGaD
Enoxacin—CYP1A2—Metabolism of lipids and lipoproteins—ACER3—melanoma	0.000191	0.00223	CbGpPWpGaD
Enoxacin—TOP2A—Integrated Pancreatic Cancer Pathway—CDKN1B—melanoma	0.000191	0.00222	CbGpPWpGaD
Enoxacin—TOP2A—Cell Cycle—APEX1—melanoma	0.000188	0.0022	CbGpPWpGaD
Enoxacin—TOP2A—Integrated Pancreatic Cancer Pathway—CASP3—melanoma	0.000187	0.00218	CbGpPWpGaD
Enoxacin—TOP2A—Cell Cycle, Mitotic—CDKN2B—melanoma	0.000182	0.00212	CbGpPWpGaD
Enoxacin—TOP2A—Integrated Pancreatic Cancer Pathway—CCND1—melanoma	0.000182	0.00212	CbGpPWpGaD
Enoxacin—TOP2A—Integrated Pancreatic Cancer Pathway—CTNNB1—melanoma	0.00018	0.0021	CbGpPWpGaD
Enoxacin—TOP2A—Integrated Pancreatic Cancer Pathway—CDKN1A—melanoma	0.000176	0.00205	CbGpPWpGaD
Enoxacin—TOP2A—Integrated Pancreatic Cancer Pathway—PTEN—melanoma	0.000176	0.00205	CbGpPWpGaD
Enoxacin—Levofloxacin—ABCB1—melanoma	0.000175	0.235	CrCbGaD
Enoxacin—TOP2A—Integrated Pancreatic Cancer Pathway—NFKB1—melanoma	0.000175	0.00204	CbGpPWpGaD
Enoxacin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IFNG—melanoma	0.000172	0.00201	CbGpPWpGaD
Enoxacin—CYP1A2—Tryptophan metabolism—MDM2—melanoma	0.000171	0.002	CbGpPWpGaD
Enoxacin—Ciprofloxacin—ABCB1—melanoma	0.000169	0.227	CrCbGaD
Enoxacin—TOP2A—Circadian rythm related genes—PTEN—melanoma	0.000169	0.00196	CbGpPWpGaD
Enoxacin—TOP2A—Cell Cycle, Mitotic—E2F1—melanoma	0.000167	0.00195	CbGpPWpGaD
Enoxacin—CYP1A2—Aryl Hydrocarbon Receptor—PTGS2—melanoma	0.000165	0.00193	CbGpPWpGaD
Enoxacin—TOP2A—Cell Cycle, Mitotic—PRKCA—melanoma	0.000164	0.00191	CbGpPWpGaD
Enoxacin—TOP2A—Cell Cycle—CDKN2B—melanoma	0.000163	0.0019	CbGpPWpGaD
Enoxacin—TOP2A—Integrated Pancreatic Cancer Pathway—VEGFA—melanoma	0.000159	0.00185	CbGpPWpGaD
Enoxacin—TOP2A—Cell Cycle, Mitotic—PCNA—melanoma	0.000158	0.00184	CbGpPWpGaD
Enoxacin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—CDKN1B—melanoma	0.000157	0.00182	CbGpPWpGaD
Enoxacin—CYP1A2—Aryl Hydrocarbon Receptor—CDKN1B—melanoma	0.000157	0.00182	CbGpPWpGaD
Enoxacin—CYP1A2—Arachidonic acid metabolism—PTGS2—melanoma	0.000155	0.0018	CbGpPWpGaD
Enoxacin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL2—melanoma	0.000153	0.00179	CbGpPWpGaD
Enoxacin—CYP1A2—Biological oxidations—CYP17A1—melanoma	0.000152	0.00177	CbGpPWpGaD
Enoxacin—TOP2A—Integrated Pancreatic Cancer Pathway—MAPK3—melanoma	0.00015	0.00175	CbGpPWpGaD
Enoxacin—CYP1A2—Metapathway biotransformation—CYP17A1—melanoma	0.00015	0.00174	CbGpPWpGaD
Enoxacin—TOP2A—Cell Cycle—E2F1—melanoma	0.00015	0.00174	CbGpPWpGaD
Enoxacin—TOP2A—Cell Cycle—PRKCA—melanoma	0.000147	0.00171	CbGpPWpGaD
Enoxacin—TOP2A—Integrated Pancreatic Cancer Pathway—MYC—melanoma	0.000146	0.0017	CbGpPWpGaD
Enoxacin—CYP1A2—Aryl Hydrocarbon Receptor—CDKN1A—melanoma	0.000144	0.00168	CbGpPWpGaD
Enoxacin—TOP2A—Cell Cycle, Mitotic—CDK2—melanoma	0.000144	0.00168	CbGpPWpGaD
Enoxacin—CYP1A2—Aryl Hydrocarbon Receptor—NFKB1—melanoma	0.000143	0.00167	CbGpPWpGaD
Enoxacin—TOP2A—Integrated Pancreatic Cancer Pathway—MAPK1—melanoma	0.000143	0.00166	CbGpPWpGaD
Enoxacin—TOP2A—Integrated Pancreatic Cancer Pathway—EGFR—melanoma	0.000143	0.00166	CbGpPWpGaD
Enoxacin—TOP2A—Cell Cycle—PCNA—melanoma	0.000141	0.00164	CbGpPWpGaD
Enoxacin—TOP2A—Cell Cycle, Mitotic—CDK4—melanoma	0.000136	0.00159	CbGpPWpGaD
Enoxacin—TOP2A—Cell Cycle—TERT—melanoma	0.000136	0.00159	CbGpPWpGaD
Enoxacin—TOP2A—Integrated Pancreatic Cancer Pathway—TNF—melanoma	0.000136	0.00158	CbGpPWpGaD
Enoxacin—TOP2A—Integrated Pancreatic Cancer Pathway—KRAS—melanoma	0.000135	0.00157	CbGpPWpGaD
Enoxacin—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—melanoma	0.00013	0.00152	CbGpPWpGaD
Enoxacin—TOP2A—Cell Cycle—CDK2—melanoma	0.000129	0.0015	CbGpPWpGaD
Enoxacin—CYP1A2—Aryl Hydrocarbon Receptor—NRAS—melanoma	0.000129	0.0015	CbGpPWpGaD
Enoxacin—CYP1A2—Biological oxidations—CYP1B1—melanoma	0.000128	0.00149	CbGpPWpGaD
Enoxacin—CYP1A2—Metapathway biotransformation—CYP1B1—melanoma	0.000126	0.00147	CbGpPWpGaD
Enoxacin—TOP2A—Integrated Pancreatic Cancer Pathway—PIK3CA—melanoma	0.000124	0.00144	CbGpPWpGaD
Enoxacin—TOP2A—Cell Cycle—ATM—melanoma	0.000122	0.00143	CbGpPWpGaD
Enoxacin—TOP2A—Cell Cycle—CDK4—melanoma	0.000122	0.00142	CbGpPWpGaD
Enoxacin—TOP2A—Integrated Pancreatic Cancer Pathway—TP53—melanoma	0.00012	0.0014	CbGpPWpGaD
Enoxacin—CYP1A2—Aryl Hydrocarbon Receptor—MYC—melanoma	0.00012	0.0014	CbGpPWpGaD
Enoxacin—TOP2A—Cell Cycle, Mitotic—RB1—melanoma	0.000119	0.00138	CbGpPWpGaD
Enoxacin—CYP1A2—Aryl Hydrocarbon Receptor—MAPK1—melanoma	0.000117	0.00137	CbGpPWpGaD
Enoxacin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EGFR—melanoma	0.000117	0.00137	CbGpPWpGaD
Enoxacin—CYP1A2—Aryl Hydrocarbon Receptor—EGFR—melanoma	0.000117	0.00137	CbGpPWpGaD
Enoxacin—CYP1A2—Metabolism of lipids and lipoproteins—PIP4K2A—melanoma	0.000116	0.00135	CbGpPWpGaD
Enoxacin—TOP2A—Circadian rythm related genes—TP53—melanoma	0.000115	0.00134	CbGpPWpGaD
Enoxacin—CYP1A2—Aryl Hydrocarbon Receptor—TNF—melanoma	0.000112	0.0013	CbGpPWpGaD
Enoxacin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—melanoma	0.000112	0.0013	CbGpPWpGaD
Enoxacin—CYP1A2—Aryl Hydrocarbon Receptor—KRAS—melanoma	0.000111	0.00129	CbGpPWpGaD
Enoxacin—TOP2A—Cell Cycle—RB1—melanoma	0.000106	0.00124	CbGpPWpGaD
Enoxacin—TOP2A—Circadian rythm related genes—IL6—melanoma	0.000105	0.00123	CbGpPWpGaD
Enoxacin—TOP2A—Cell Cycle, Mitotic—CDKN2A—melanoma	0.000104	0.00121	CbGpPWpGaD
Enoxacin—TOP2A—Integrated Pancreatic Cancer Pathway—AKT1—melanoma	0.000101	0.00118	CbGpPWpGaD
Enoxacin—CYP1A2—Metabolism of lipids and lipoproteins—CUBN—melanoma	9.67e-05	0.00113	CbGpPWpGaD
Enoxacin—CYP1A2—Aryl Hydrocarbon Receptor—HRAS—melanoma	9.41e-05	0.0011	CbGpPWpGaD
Enoxacin—TOP2A—Cell Cycle—CDKN2A—melanoma	9.32e-05	0.00109	CbGpPWpGaD
Enoxacin—TOP2A—Cell Cycle, Mitotic—CDKN1B—melanoma	9.23e-05	0.00108	CbGpPWpGaD
Enoxacin—CYP1A2—Metabolism of lipids and lipoproteins—GPAM—melanoma	9.04e-05	0.00105	CbGpPWpGaD
Enoxacin—TOP2A—Cell Cycle—MDM2—melanoma	9.04e-05	0.00105	CbGpPWpGaD
Enoxacin—TOP2A—Cell Cycle, Mitotic—CCND1—melanoma	8.81e-05	0.00103	CbGpPWpGaD
Enoxacin—TOP2A—Cell Cycle, Mitotic—CDKN1A—melanoma	8.52e-05	0.000993	CbGpPWpGaD
Enoxacin—CYP1A2—Metabolism—ACER3—melanoma	8.51e-05	0.000992	CbGpPWpGaD
Enoxacin—TOP2A—Cell Cycle—CDKN1B—melanoma	8.25e-05	0.000962	CbGpPWpGaD
Enoxacin—TOP2A—Cell Cycle—CCND1—melanoma	7.87e-05	0.000918	CbGpPWpGaD
Enoxacin—CYP1A2—Metabolism—UGT2B10—melanoma	7.79e-05	0.000907	CbGpPWpGaD
Enoxacin—CYP1A2—Metabolism of lipids and lipoproteins—PLA2G6—melanoma	7.69e-05	0.000896	CbGpPWpGaD
Enoxacin—TOP2A—Cell Cycle—CDKN1A—melanoma	7.62e-05	0.000888	CbGpPWpGaD
Enoxacin—TOP2A—Cell Cycle, Mitotic—MAPK3—melanoma	7.26e-05	0.000847	CbGpPWpGaD
Enoxacin—CYP1A2—Metabolism—HS3ST5—melanoma	7.24e-05	0.000844	CbGpPWpGaD
Enoxacin—TOP2A—Cell Cycle, Mitotic—MYC—melanoma	7.06e-05	0.000823	CbGpPWpGaD
Enoxacin—TOP2A—Cell Cycle, Mitotic—MAPK1—melanoma	6.91e-05	0.000805	CbGpPWpGaD
Enoxacin—TOP2A—Cell Cycle—MAPK3—melanoma	6.49e-05	0.000757	CbGpPWpGaD
Enoxacin—TOP2A—Cell Cycle—MYC—melanoma	6.32e-05	0.000736	CbGpPWpGaD
Enoxacin—TOP2A—Cell Cycle—MAPK1—melanoma	6.18e-05	0.00072	CbGpPWpGaD
Enoxacin—CYP1A2—Metabolism of lipids and lipoproteins—CYP17A1—melanoma	5.83e-05	0.000679	CbGpPWpGaD
Enoxacin—CYP1A2—Metabolism—PLCB4—melanoma	5.49e-05	0.000639	CbGpPWpGaD
Enoxacin—CYP1A2—Metabolism of lipids and lipoproteins—FASN—melanoma	5.38e-05	0.000628	CbGpPWpGaD
Enoxacin—TOP2A—Cell Cycle—TP53—melanoma	5.19e-05	0.000605	CbGpPWpGaD
Enoxacin—CYP1A2—Metabolism—PIP4K2A—melanoma	5.16e-05	0.000601	CbGpPWpGaD
Enoxacin—CYP1A2—Metabolism—SLC6A11—melanoma	5.16e-05	0.000601	CbGpPWpGaD
Enoxacin—CYP1A2—Metabolism—MTAP—melanoma	5.02e-05	0.000585	CbGpPWpGaD
Enoxacin—CYP1A2—Metabolism of lipids and lipoproteins—CYP1B1—melanoma	4.9e-05	0.000572	CbGpPWpGaD
Enoxacin—CYP1A2—Metabolism—PHGDH—melanoma	4.47e-05	0.000521	CbGpPWpGaD
Enoxacin—CYP1A2—Metabolism—LUM—melanoma	4.47e-05	0.000521	CbGpPWpGaD
Enoxacin—CYP1A2—Metabolism—HPSE—melanoma	4.39e-05	0.000511	CbGpPWpGaD
Enoxacin—CYP1A2—Metabolism—CUBN—melanoma	4.3e-05	0.000502	CbGpPWpGaD
Enoxacin—CYP1A2—Metabolism—SDHD—melanoma	4.16e-05	0.000485	CbGpPWpGaD
Enoxacin—CYP1A2—Metabolism—BSG—melanoma	4.16e-05	0.000485	CbGpPWpGaD
Enoxacin—CYP1A2—Metabolism—CSPG4—melanoma	4.16e-05	0.000485	CbGpPWpGaD
Enoxacin—CYP1A2—Metabolism—GPAM—melanoma	4.03e-05	0.000469	CbGpPWpGaD
Enoxacin—CYP1A2—Metabolism—PLA2G6—melanoma	3.42e-05	0.000399	CbGpPWpGaD
Enoxacin—CYP1A2—Metabolism—VCAN—melanoma	3.08e-05	0.000358	CbGpPWpGaD
Enoxacin—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—melanoma	2.91e-05	0.000339	CbGpPWpGaD
Enoxacin—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—melanoma	2.81e-05	0.000327	CbGpPWpGaD
Enoxacin—CYP1A2—Metabolism—CYP17A1—melanoma	2.59e-05	0.000302	CbGpPWpGaD
Enoxacin—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CD—melanoma	2.56e-05	0.000298	CbGpPWpGaD
Enoxacin—CYP1A2—Metabolism of lipids and lipoproteins—ALB—melanoma	2.53e-05	0.000294	CbGpPWpGaD
Enoxacin—CYP1A2—Metabolism—GNA11—melanoma	2.45e-05	0.000286	CbGpPWpGaD
Enoxacin—CYP1A2—Metabolism—FASN—melanoma	2.4e-05	0.000279	CbGpPWpGaD
Enoxacin—CYP1A2—Metabolism—SLC5A5—melanoma	2.36e-05	0.000275	CbGpPWpGaD
Enoxacin—CYP1A2—Metabolism—GNAQ—melanoma	2.28e-05	0.000265	CbGpPWpGaD
Enoxacin—CYP1A2—Metabolism—CD44—melanoma	2.28e-05	0.000265	CbGpPWpGaD
Enoxacin—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CB—melanoma	2.23e-05	0.00026	CbGpPWpGaD
Enoxacin—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—melanoma	2.21e-05	0.000258	CbGpPWpGaD
Enoxacin—CYP1A2—Metabolism—CYP1B1—melanoma	2.18e-05	0.000255	CbGpPWpGaD
Enoxacin—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—melanoma	1.93e-05	0.000225	CbGpPWpGaD
Enoxacin—CYP1A2—Metabolism—ABCB1—melanoma	1.8e-05	0.00021	CbGpPWpGaD
Enoxacin—CYP1A2—Metabolism—PRKCA—melanoma	1.66e-05	0.000193	CbGpPWpGaD
Enoxacin—CYP1A2—Metabolism—ERCC2—melanoma	1.64e-05	0.000191	CbGpPWpGaD
Enoxacin—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—melanoma	1.36e-05	0.000158	CbGpPWpGaD
Enoxacin—CYP1A2—Metabolism—PIK3CG—melanoma	1.3e-05	0.000151	CbGpPWpGaD
Enoxacin—CYP1A2—Metabolism—PPARG—melanoma	1.25e-05	0.000146	CbGpPWpGaD
Enoxacin—CYP1A2—Metabolism—PIK3CD—melanoma	1.14e-05	0.000133	CbGpPWpGaD
Enoxacin—CYP1A2—Metabolism—ALB—melanoma	1.13e-05	0.000131	CbGpPWpGaD
Enoxacin—CYP1A2—Metabolism—PIK3CB—melanoma	9.93e-06	0.000116	CbGpPWpGaD
Enoxacin—CYP1A2—Metabolism—PTGS2—melanoma	9.84e-06	0.000115	CbGpPWpGaD
Enoxacin—CYP1A2—Metabolism—PTEN—melanoma	8.58e-06	0.0001	CbGpPWpGaD
Enoxacin—CYP1A2—Metabolism—PIK3CA—melanoma	6.06e-06	7.06e-05	CbGpPWpGaD
Enoxacin—CYP1A2—Metabolism—AKT1—melanoma	4.95e-06	5.77e-05	CbGpPWpGaD
